Introduction
============

Cataract, characterized by opacification or optical dysfunction of the lens, has been a leading cause of blindness worldwide. It usually develops very slowly and gradually with age. A report by World Health Organization shows that the total number of persons with cataracts is estimated to rise to 30.1 million by 2020, and it differs from country to country.[@b1-dddt-12-1399] Cataract has become a disease starving for treatment. Various studies have confirmed that multiple risk factors such as diet, diabetes, daylight, dehydration, oxidation of lens proteins, and peroxidation of lipids influence the generation of lens opacities in older individuals.[@b2-dddt-12-1399] Among the various causes, oxidative stress is considered to play a key role in the molecular mechanism of cataract formation.[@b3-dddt-12-1399] Oxidative stress occurs when the level of pro-oxidants surpasses the level of antioxidants. Free radicals, including numerous reactive oxygen species (ROS) such as superoxide anion radical, H~2~O~2~, and hydroxyl free radical, may affect the structure and function of the lens, modulate aggregation of the lens, and contribute to cataract formation.[@b4-dddt-12-1399] Excessive free radical generation leading to oxidative stress has been identified as one of the major triggering factors for senile cataract formation.[@b5-dddt-12-1399] As a result, efforts have been taken to develop an effective antioxidant treatment, both of synthetic and plant origins in delaying the onset and the progression of cataract.[@b6-dddt-12-1399]

Baicalin (5,6,7-trihydroxyflavone-7-β-[d]{.smallcaps}-glucuronide) is a major flavonoid derived from the root of *Scutellaria baicalensis* Georgi (Scutellariae Radix). A series of studies have proven that it is an effective antioxidant, antiviral, anti-inflammatory, antitumor,[@b7-dddt-12-1399] etc.[@b50-dddt-12-1399]--[@b52-dddt-12-1399] Flavonoids, found in various foods and beverages, have strong anti-cataract and antioxidant activities.[@b8-dddt-12-1399] In recent years, solid lipid nanoparticles (SLNs) have been proposed as a new ophthalmic delivery system, which can enhance residence time on the ocular surface and improve the bioavailability of drugs.[@b9-dddt-12-1399] In our recent study, SLNs of baicalin (BA-SLNs)[@b10-dddt-12-1399] and reported it as an efficient ROS scavenger upregulating glutathione (GSH) level and superoxide dismutase (SOD) activity in a BA-SLNs' treatment group of sodium selenite-induced cataractic rats.[@b11-dddt-12-1399] With its quick and reproducible properties, the selenite-induced cataract model has been commonly used for studying the mechanism of age-related cataract formation. Recent works on baicalin have also provided several interesting new findings, relevant to our current study. Zhao et al[@b12-dddt-12-1399] reported that mice fed with a baicalin-containing diet for 50 days showed an increased antioxidative status and decreased iron content and lipid peroxidation in the liver after iron overload. We therefore considered BA-SLNs to be a potentially useful antioxidant and anti-cataract agent. At present, there is no reported study on the antioxidant properties of BA-SLNs with regard to cataract formation. Therefore, we proceeded to find out the molecular mechanism of the anti-cataract effect of this novel baicalin ophthalmic preparation.

With the progress in proteomic analysis, proteomic approaches have been applied to identify proteins in various physiological or pathological conditions in organelles, cells, organisms, and extracellular body fluids.[@b13-dddt-12-1399]--[@b15-dddt-12-1399] Two-dimensional gel electrophoresis (2-DE) has been a classic method of preparation of microanalytical amounts of starting material for protein analysis. Mass spectrometry (MS), a powerful tool, has also been used to successfully identify proteins. Researchers have used this method to analyze the proteome of cataractic or normal lenses.[@b16-dddt-12-1399],[@b17-dddt-12-1399] Thus, we applied this method to investigate the effect of BA-SLNs on the proteome of cataractic lens. Differential expression patterns of the lens proteome with or without administration of BA-SLNs were obtained by employing 2-DE. Protein spots that showed ±2-fold different protein expressions between the two conditions were then subjected to nano-liquid chromatography tandem mass spectrometry (LC--MS/MS) and the identity of the proteins was obtained. Bioinformatics was performed to comprehend the biological implications of the proteins identified by proteomics. Ingenuity pathway analysis (IPA) was used to analyze the data. To the best of our knowledge, this is the first report that looks into the differential proteomic profile of cataract in response to BA-SLNs' treatment. This study could serve as a basis for further clinical investigations.

Materials and methods
=====================

Materials
---------

Immobilized Ph gradient (IPG) gel strip (Bio-Rad Laboratories Inc., Hercules, CA, USA), 3-\[(3-cholamidopropyl) dimethylammonio\] propanesulfonic acid (CHAPS) (Sigma-Aldrich Co., St Louis, MO, USA), urea (Sangon Biotech Co.,Ltd, Shanghai, People's Republic of China), iodoac-etamide (Sigma-Aldrich Co.), thiourea (Tianjin Chemical Reagent Factory, Tianjin, People's Republic of China), PH3-10 ampholytes (Bio-Rad Laboratories Inc.), phenylmethanesulfonyl fluoride (PMSF) (Sigma-Aldrich Co.), acetonitrile (ACN) (Thermo Fisher Scientific, Waltham, MA, USA), dithiothreitol (DTT) (Merck Millipore, Billerica, MA, USA), iodoacetamide (Aladdin), formic acid (Alfa Aesar, shanghai, People's Republic of China), trypsin solution (purified by the laboratory), and baicalin (\>98%; Zhong Xin Pharmaceuticals, Tianjin, China) were used. Soya phospho-lipids SL-100 was acquired from Lipoid (Rheinland-Pfalz, Ludwigshafen, Germany). Poloxamer 188 was obtained from BASF (Deutschland, Ludwigshafen, Germany). Triglyceride was purchased from Tianjin North Tianyi Chemical Agent Factory, Tianjin, People's Republic of China. All other chemicals and reagents were of analytical grade.

Animals
-------

Wistar rat pups (aged 9 days) were supplied by Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, China. The animals were housed in a temperature-controlled room with a 12 h light and dark cycle and provided with free access to water and food. All studies were conducted in accordance with the Principles of Laboratory Animal Care (NIH publication no 92-93, revised in 1985) and were approved by the Department of Laboratory Animal Research at the Tianjin University of Traditional Chinese Medicine. All experiments were performed with approval from the Laboratory Animal Ethics Committee of Tianjin University of Traditional Chinese Medicine (approval number TCM-LAEC2013010). The rats were acclimatized for a period of 3 days in the new environment before the initiation of the experiment. Efforts were made to minimize animals suffering.

Drug administration and induction of cataract
---------------------------------------------

Cataract rat model was induced with sodium selenite according to a previously reported method (Shearer et al, 1997; Elanchezhian et al, 2009) with a minor modification.[@b5-dddt-12-1399],[@b18-dddt-12-1399] Briefly, rat pups were randomly separated into blank, control, and treatment groups (n=10). At 12 days of age (20--25 g), before opening of their eyelids, the control and treatment groups received a single subcutaneous injection of sodium selenite (25 µmol/kg), whereas the blank group received saline. Then, 20 µL of 0.1% BA-SLNs as eye drops was given to the treatment group, meanwhile same volume of saline was given to the blank and control groups. Drug was administered three times a day for 4 days. Changes in the lens were observed daily by slit-lamp (YZ2, Suzhou, China) and photography. Lenticular opacity was graded as described by Hiraoka and Clark.[@b19-dddt-12-1399] At the end of 4 days, the rat pups were sacrificed by cervical dislocation. Their lenses were severed from the eyes leaving the lens capsule intact and stored at −80°C until required.

Preparation of protein for electrophoretic analysis
---------------------------------------------------

The lenses in every group were homogenized by ultrasound disintegration on ice for 10 s per 0.5 s interval in lysate containing 8 M urea, 2 M thiourea, 2% CHAPS, 2% ampholytes, 1% DTT, and 1 mM PMSF with 50 mM deoxyribonuclease I (Dnase I). Proteins were obtained from the supernatant by centrifugation at 12,000 rpm for 30 min at 4°C and frozen at −80°C prior to analysis.

Two-dimensional gel electrophoresis
-----------------------------------

The protein concentration was measured by the Bradford method with the loading quantity being 0.8 mg per sample from each of the three groups. 2-DE was performed with a horizontal isoelectric focusing (IEF) system (Multiphor II, Amersham Bioscience, USA), using precast immobilized linear-gradient (IPG, pH 3--10) strips for the first dimension, and 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) for the second dimension. The SDS-PAGE was run in a Multi-Gel Casting Chamber (Bio-Rad Laboratories Inc.). Initially, IPG gel strip was rehydrated in buffer (8 M urea, 2 M thiourea, 0.5% CHAPS, 0.52% ampholytes, 0.02% bromophenol blue, 1% DTT) for 12 h and IEF performed with the following voltage program: 0--500 V (rapid for 500 V⋅h), 500 V (linear \>2,500 V⋅h), 500--3,500 V (rapid for 10,000 V⋅h), 3,500 V (linear \>50,000 V⋅h), and 3,500--500 V (rapid for 8,000 V⋅h). Focused IPG strips were equilibrated for 15 min with equilibration buffer-I (50 mM Tris-HCl \[pH 6.8\], 6 M urea, 30% \[v/v\] glycerol, 0.02% bromophenol blue, 2% SDS, 2% \[w/v\] DTT) and 15 min with equilibration buffer-II (50 mM Tris-HCl \[pH 6.8\], 6 M urea, 30% \[v/v\] glycerol, 0.02% bromophenol blue, 2% SDS, 2.5% \[w/v\] iodoacedamide). The second-dimensional SDS-PAGE with a 12% running gel was performed first at a constant current of 15 mA/gel for 15 min and then at 250 V/gel till the bromophenol blue reached the bottom of the gel. After electrophoresis, the gels were stained with staining buffer (0.12% Coomassie brilliant blue G-250, 10% ammonium sulfate, 10% phosphoric acid, 20% methanol) overnight. After being destained, images were obtained using UMAX Powerlook 2100XL (UMAX, Taipei, China) at a resolution of 300 dpi and analyzed using the PDQuest 8.0.1 software (Bio-Rad Laboratories Inc.). Protein spot expression levels were analyzed as follows: protein spots from each gel were detected and matched automatically to generate a master gel image from the matched gel sets. Data were exported to Microsoft Excel (Microsoft Corporation, Redmond, WA, USA) for creating correction and spot intensity graphs. Finally, the intensity of the spots was compared between gels.

Nano-LC--MS/MS analysis and database searching
----------------------------------------------

Gel pieces of interest were excised from gels, rinsed by Milli-Q water three times, and then destained with 50 mM NaHCO~3~, 50% ACN until completely destained. The destained gel pieces were washed with 100% ACN and then dried. Reduction and alkylation in 10 mM DTT and 50 mM iodoacetamide, respectively, were followed by washing with 25 mM NaHCO~3~ twice and then with 25 mM NaHCO~3~ in 50% ACN solution also twice and then dried. The dried gel pieces were rehydrated with 10 µL of trypsin solution (20 µg/mL) for 10 min at 4°C. After the addition of 25 mM NH~4~HCO~3~, the samples were incubated at 37°C overnight. Following enzymatic digestion, peptides were triple extracted from the gel using 25 µL of extraction buffer and the supernatants were combined. All peptide digestion mixtures were dried and dissolved in sample buffer (0.1% formic acid in 5% ACN). Solvents for nano-LC--MS/MS separation of the digested samples were as follows: solvent A consisted of 0.1% formic acid in water and solvent B consisted of 0.1% formic acid in ACN. The peptides were eluted from the analytical column (CTICAP5150100; Column Technology Inc., USA), at a flow rate of 2 µL/min equilibrating with 5% of solvent B for 15 ms, followed by a 45 ms gradient from 5 to 32% of solvent B, then to 90% solvent B within 35 ms, and to 5% solvent B within 5 ms and, finally, maintained for 20 ms. For protein identification, nano-LC--MS/MS analysis was conducted using LTQ XL (Thermo Fisher Scientific) (electrospray ionization tandem MS \[ESI--MS/MS\]). The instrument was operated with a spray voltage of 3.5 kV and an ion transfer tube temperature of 250°C. The information-dependent acquisition (IDA) mode of operation was employed, in which a survey scan from *m*/*z* 400 to 1,800 was acquired, followed by collision-induced dissociation (CID). Normalized collision energy of 35% with an activation *q* of 0.25 for 30 ms was used for the MS/MS. Ion selection thresholds for MS and MS/MS were 1,000 and 500 counts, respectively. Regarding protein search algorithm for peptide mass identification, tandem mass spectra were extracted by Xcalibur Version 1.0.0.2. All MS/MS samples were analyzed using Sequest. Iodoacetamide derivative of Cys, deamidation of Asn and Gln, and oxidation of Met were specified in Sequest as variable modifications. MS/MS-based peptides and proteins were retrieved from rat.fasta from NCBI database using the Proteome Discoverer 1.2 software.

Proteome Discoverer 1.2 was used to validate MS/MS-based peptide and protein identification. Peptide identification was accepted if they could be established at \>95.0% probability as specified by the result filter, where Xcorr \>1.9 if Charge =1, Xcorr \>2.2 if Charge =2, and Xcorr \>3.75 if Charge =3. Protein identification was also accepted if established at \>99.0% probability and contains at least two identified unique peptides.

Bioinformatic analysis of biological networks
---------------------------------------------

Gene Ontology annotation, pathways, and protein interaction network analysis were performed to comprehend the biological implications of proteins identified by proteomics using the IPA online software.

Statistical analysis
--------------------

Differences in protein spots' content between the BA-SLNs and model groups were analyzed using a test (n=3), only those with ±2-fold expressed change were considered as significantly differentially expressed proteins when comparing BA-SLNs group with model group. Gene Ontology annotation, pathway, and network analysis were performed to elaborate the interaction of proteins identified by proteomics.

Results
=======

Effect of BA-SLNs on sodium selenite-induced cataract progression
-----------------------------------------------------------------

Lens transparency was observed daily. After 4 days, Stage 4 cataract formation (partial nuclear opacity) was observed in almost all lenses in the model group (Stage 4, [Figure 1A](#f1-dddt-12-1399){ref-type="fig"}). However, all lenses were clear and normal in the blank group (Stage 0, [Figure 1B](#f1-dddt-12-1399){ref-type="fig"}). In the BA-SLNs group, the lenses displayed early posterior subcapsular cataract or minimal nuclear opacity (Stage 1, [Figure 1C](#f1-dddt-12-1399){ref-type="fig"}) and there was no significant difference between the BA-SLNs group and the blank group. The result suggested that the progression of cataract due to sodium selenite-induced oxidative stress, from onset through maturation, was delayed in the group, which received 0.1% BA-SLNs.

Effect of BA-SLNs on protein expression
---------------------------------------

DE patterns of total proteins of lenses from each group were obtained by imaging. Comparative 2-DE-based proteomic analysis was performed between gels. As shown in the images ([Figure 2](#f2-dddt-12-1399){ref-type="fig"}), the proteins varied between 20 and 100 kDa in size and had isoelectric point (pI) values ranging from 4 to 8. Comparing the intensity of the spots (±2-fold expressed change), 134 protein spots were differentially expressed between the blank and the model groups, indicating that sodium selenite influences protein expression in lenses to induce cataract. There were 144 and 119 protein spots that were differentially expressed, comparing the BA-SLNs group with the model and the blank groups respectively. Therefore, we concluded that BA-SLNs targeted some proteins and regulated their expression level to delay cataract progression. Considering the limitation of 2-DE and the significance of proteins, we selected 65 protein spots that were differentially expressed between the BA-SLNs and the model groups but similarly expressed between the BA-SLNs and the blank groups. These protein spots were unequivocally identified by peptide mass fingerprinting (PMF). The results were validated by the Proteome Discoverer 1.2 software and were evaluated and determined based on scores, numbers of matched segments, and cover ratio in combination with the molecular mass and isoelectric point (pI) of the protein spot on 2-DE. A total of 23 proteins have been identified from the 65 differentially expressed proteins including vimentin, tryptophan 5-monooxygenase activation protein, tubulin beta-5 chain, beaded filament structural protein 2, beaded filament structural protein 1, heat shock protein beta-1, glutaredoxin-3, serine-tRNA ligase, elongation factor-1 alpha, malate dehydrogenase 1, alpha-crystallin A, alpha-crystallin B, beta-crystallin A4, beta-crystallin A1, beta-crystallin B1, beta-crystallin B2, beta-crystallin B3, gamma-crystallin A, gamma-crystallin B, gamma-crystallin C, gamma-crystallin F, gamma-crystallin D, and hydrogenated rat gamma E crystallin. Their characteristics are shown in [Table 1](#t1-dddt-12-1399){ref-type="table"} with distributions indicated by the arrows ([Figure 2](#f2-dddt-12-1399){ref-type="fig"}). Of these, 12 proteins were upregulated and 11 proteins were downregulated in sodium selenite-induced rat lens. Comparing the intensity of each protein in the model group with the blank group, upregulated proteins were 12, which include eight crystalline proteins. We therefore considered crystalline protein to play an important role in preserving the normal expression level of proteins and the transparency of the lens. The BA-SLN-treated lenses' data showed a general trend that BA-SLNs regulated the protein expression mode from cataract to normal lens protein expression. The 12 upregulated proteins were downregulated by BA-SLNs to normal degrees, while the 11 downregulated proteins were upregulated by this drug. We therefore concluded that BA-SLNs can delay cataract progression by regulating protein expression.

Bioinformatics analysis
-----------------------

Compared with the model group of sodium selenite-induced cataract rat, BA-SLNs could reverse the abnormal level of 23 proteins and then import these proteins into the IPA software for pathway and network analysis, 22 differentially expressed proteins were mapped ([Table 2](#t2-dddt-12-1399){ref-type="table"}). The top canonical pathways of these proteins were 14-3-3-mediated signaling, aldosterone signaling in epithelial cells, protein ubiquitination pathway, aspartate degradation II, selenocysteine biosynthesis II (Archaea and Eukaryotes), etc; the result is shown in [Figure 3A and B](#f3-dddt-12-1399){ref-type="fig"}. To further investigate the relative disease and bio-functions among the altered proteins and explore the main proteins of BA-SLNs against sodium selenite-induced cataract rat, bioinformatics analysis showed that these reversed proteins was most relative with developmental disorder, ophthalmic disease, and organismal injury and abnormalities; its molecular and cellular functions were associated with cell death and survival, post-translational modification, and protein folding, and its physiological system development and function were embryonic development, nervous system development and function, organ development; the relative disease and bio-functions' result are shown in [Figure 3C and D](#f3-dddt-12-1399){ref-type="fig"}. Two major interaction networks were identified ([Table 3](#t3-dddt-12-1399){ref-type="table"}). The developmental disorder, ophthalmic disease, and organismal injury and abnormalities-related network was the highest scoring network with 18 identified proteins out of a possible 36 molecules associated with the network ([Figure 4](#f4-dddt-12-1399){ref-type="fig"}). This was followed with embryonic development, nervous system development and function, and organ development, with four identified proteins out of 35 molecules associated with the network. The snapshot ([Figure 5](#f5-dddt-12-1399){ref-type="fig"}) shows the interactions found in the query data; we constructed a network of 18 proteins.

Discussion
==========

Very few therapies have been shown to cure or prevent cataracts effectively, with the only effective treatment being surgery.[@b20-dddt-12-1399] Though cataract surgery is recognized as being safe with a high success rate, there is a significant rate of complications leading to irreversible blindness. Its affordability, acceptability, and accessibility are also limited. It is therefore relevant and important to look for alternative pharmacological measures for treating this disorder. Exploring the mechanisms of cataractogenesis and applying pharmacological interventions are crucial steps required to inhibit or delay lens opacification. Thus, we decide to explore a dosage form of a natural compound with a potent anti-cataract effect.

Ten to fourteen day old suckling rats were single sub-injected once with sodium selenite 19 -30 μmol/kg body weight, and then, selenite cataract was produced within 4--6 days. Selenite causes nuclear opacity by inducing oxidative stress in lens tissue. Similar to age-related cataract, several biochemical processes such as altered epithelial metabolism, calcium accumulation, crystalline precipitation, and cytoskeletal loss occur during the development of selenite-induced cataract. It is generally accepted that selenite administration results in hydrogen peroxide formation, lipid peroxidation, decrease in activities of the antioxidant enzymes such as SOD, and reduced GSH levels.[@b21-dddt-12-1399] Results from a previous study showed that the activities of SOD and GSH were significantly higher in BA-SLN-treated cataract group compared to the nontreated group.[@b11-dddt-12-1399] BA-SLNs therefore protect the lens from oxidant damage due to toxic chemicals. In this study, morphological cataract staging was used to evaluate the morphological effects of BA-SLNs. The result suggests that BA-SLNs play an important role in delaying the onset and progression of cataract.

2D-PAGE, which provides high resolution of complex protein mixtures, was used in this study to separate proteins. Definitive protein identification has traditionally been conducted by nano-LC--MS/MS, and thus, this conventional method was also applied. These methods have become the main and preferred techniques in proteomics research.[@b22-dddt-12-1399] A total of 23 proteins have been identified from the 65 differentially expressed proteins. Of these, 12 proteins were upregulated and 11 proteins were downregulated in sodium selenite-induced rat lens. However, many proteins were not identified. Reasons may be as follows: first, the proteins of rat pups' lenses are incomplete as the lenses are still growing and as such many of these proteins are absent in the database and, second, the identification of an individual protein is related to the present individual protein's abundance in the lens. As such, some trace proteins have not been detected by this procedure.

To better understand the biological context and involvement in diverse pathways of the sodium selenite-induced differentially expressed proteins in rat lens, we performed functional pathway analysis using the ingenuity pathway analysis (IPA) database. The core analysis with the IPA software to the canonical pathway indicated that the target proteins of model and BA-SLNs genes were involved with pathways of 14-3-3-mediated signaling, aldosterone signaling in epithelial cells, etc. 14-3-3-Mediated signaling is mostly related to apoptosis and cell cycle regulation including VIM, TUBB, and YWHAE of these 23 differentially expressed proteins.

Vimentin encodes a member of the intermediate filament family. Intermediate filaments, along with microtubules and actin microfilaments, make up the cytoskeleton. The protein encoded by this gene is responsible for maintaining cell shape and integrity of the cytoplasm and stabilizing cytoskeletal interactions. Mutations in this gene cause a dominant, pulverulent cataract.[@b23-dddt-12-1399] TUBB encodes a beta-tubulin protein. It forms a dimer with alpha-tubulin and acts as a structural component of microtubules. YWHAE product belongs to the 14-3-3 family of proteins, which mediate signal transduction by binding to phosphoserine-containing proteins.

Aldosterone signaling in epithelial cells is a nuclear receptor signaling. It includes CRYAA/LOC102724652, CRYAB, and HSPB1. Mammalian lens crystallins are divided into alpha, beta, and gamma families. Alpha crystallins are composed of two gene products, such as alpha-A and alpha-B, for acidic and basic, respectively. Alpha crystallins can be induced by heat shock and are members of the small heat shock protein (sHSP; HSP20) family. Two additional functions of alpha crystallins are an autokinase activity and participation in the intracellular architecture. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Alpha-A and alpha-B gene products are differentially expressed; alpha-A is preferentially restricted to the lens and alpha-B is expressed widely in many tissues and organs. Defects in this gene cause autosomal dominant congenital cataract (ADCC). Elevated expression of alpha-B crystallin occurs in many neurological diseases. The protein encoded by HSPB1 is induced by environmental stress and developmental changes. The encoded protein is involved in stress resistance and actin organization and translocates from the cytoplasm to the nucleus upon stress induction. Protein ubiquitination pathway is an intracellular and second messenger signaling. It also includes CRYAA/LOC102724652, CRYAB, and HSPB1. Protein--protein interactions (PPIs) play crucial roles in every biological process.[@b24-dddt-12-1399]--[@b26-dddt-12-1399] Protein interaction networks are represented by nodes and edges where nodes represent proteins while edges represent interactions between proteins.[@b27-dddt-12-1399],[@b28-dddt-12-1399] [Figure 5](#f5-dddt-12-1399){ref-type="fig"} represents the conjunctions of protein, which means that the higher the connection, the more important the protein is. A previous study reported that proteins with the highest number of interactions are the most essential proteins for survival.[@b29-dddt-12-1399] CRYAB, the highest connected protein, had relations with an other nine proteins. CRYAA related with an other eight proteins. HSPB1 had relations with an other seven proteins, indicating that CRYAB, CRYAA, and HSPB1 might play very important roles in the whole network. Previous studies have shown that sHSPs belong to molecular chaperones, which are essential elements in cellular protection.[@b30-dddt-12-1399]--[@b32-dddt-12-1399] By forming stable complexes with folding or unfolding intermediate protein substrates, probably the molten globule, the sHSPs (which include alpha crystallin) can form large multimeric structures and have a wide range of cellular functions, including endowing cells with thermotolerance in vivo and being able to act as molecular chaperones in vitro.[@b33-dddt-12-1399],[@b34-dddt-12-1399] Among them, HSPB1, HSPB4, and HSPB5 are responsible for the development of cataract, oncogenesis, and antiapoptotic activity.[@b35-dddt-12-1399]--[@b37-dddt-12-1399] The lens is largely formed from α-crystallin and βγ-crystallin superfamily with the main cellular partners of α-, β-, and γ-crystallin being abundant in vertebrate eye lens.[@b38-dddt-12-1399] Besides transparency, the major role of the partnership of α-crystallin with β- and γ-crystallin in the lens is to form a refractive index gradient.[@b39-dddt-12-1399]--[@b41-dddt-12-1399] As many studies showed, the α-crystallin is an evolutionarily related group of sHSPs that play a role in producing and maintaining the transparency and refractive power of the vertebrate's ocular lens.[@b42-dddt-12-1399]--[@b44-dddt-12-1399] Under various stresses, the inducibility of HSPs and α-crystallin transcription is exerted by HSF-dependent mechanisms, by which concomitant induction of HSPs and α-crystallin expression is observed.[@b45-dddt-12-1399],[@b46-dddt-12-1399] Functional changes in α-crystallin have been shown to modify membrane and cell--cell interactions and lead to lens cell pathology in vivo.[@b47-dddt-12-1399]--[@b49-dddt-12-1399] Therefore, these proteins are potential therapeutic targets in many diseases. This study also provided other proteins as candidates that play a role in the lens. However, further experimental validation is needed to demonstrate the molecule mechanism in cataract. This study can lead to the development of new treatment for cataract.

Conclusion
==========

In present study, we used sodium selenite-induced cataract rat model to look into the lens transparency in response to BA-SLNs' treatment for the first time, which indicated that BA-SLNs play an important role in delaying the onset and progression of cataract. 2D-PEGA combined with the highly sensitive nano-LC--MS/MS method was employed to analyze the differential proteomic profile of the lens. A total of 23 proteins were identified by this proteomics analysis among the differentially expressed proteins, appearing to be implicated in the progression of cataract formation. Bioinformatic analysis was employed to better understand the identified proteins including classification by biological process, cellular component, molecular function and construction of pathways, and PPIs' network analysis, which would be significant to the study of the lens proteins of rat in the future. This study could serve as a basis for further clinical investigations.
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![Cataract formation in three groups.\
**Notes:** (**A**) Model group (Stage 4 cataract). (**B**) Blank group (Stage 0 cataract). (**C**) BA-SLNs group (Stage 1 cataract).\
**Abbreviation:** BA-SLNs, solid lipid nanoparticles of baicalin.](dddt-12-1399Fig1){#f1-dddt-12-1399}

![Two dimensional gel images from lenses of three groups.\
**Notes:** Arrows indicate differently expressed protein spots that were identified using nano-LC--MS/MS. (**A**) Model group. (**B**) Blank group. (**C**) BA-SLNs group.\
**Abbreviations:** BA-SLNs, solid lipid nanoparticles of baicalin; LC--MS/MS, liquid chromatography tandem mass spectrometry.](dddt-12-1399Fig2){#f2-dddt-12-1399}

###### 

Ingenuity pathways' analysis of expression proteins.

**Notes:** (**A**) Top canonical pathways identified by IPA that are searched of lens proteins. (**B**) IPA reveals a network of signaling pathways searched by lens proteins. (**C**) The biologically active functions' network of main lens proteins. (**D**) The biological functions of lens proteins.

**Abbreviation:** IPA, Ingenuity Pathway Analysis.
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![Functional pathway analysis using the IPA database.\
**Notes:** The network indicates the interaction network among differentially expressed proteins. Nodes show genes or gene products. A direct relation between nodes is demonstrated by solid lines, and an indirect relation between nodes is demonstrated by dashed lines.](dddt-12-1399Fig4){#f4-dddt-12-1399}

![Direct interactions found in query data in string database.](dddt-12-1399Fig5){#f5-dddt-12-1399}

###### 

Characteristics of identified proteins using nano-LC--MS/MS

  Proteins   Score      Peptides   Accession     Description                                     PI/Mr
  ---------- ---------- ---------- ------------- ----------------------------------------------- -----------
  1          458.73     32         gi14389299    Vimentin                                        5.12/53.7
  2          313.34     18         gi38648857    Tryptophan 5-monooxygenase activation protein   4.74/29.2
  3          591.35     24         gi27465535    Tubulin beta-5 chain                            4.89/49.6
  4          1,221.53   32         gi476007854   Beaded filament structural protein 2            5.39/45.7
  5          71.78      9          gi158186655   Beaded filament structural protein 1            6.01/73.0
  6          118.26     8          gi94400790    Heat shock protein beta-1                       6.55/22.8
  7          211.70     16         gi78187979    Glutaredoxin-3                                  5.72/37.8
  8          248.08     21         gi56090265    Serine-tRNA ligase                              6.19/58.6
  9          321.36     13         gi1220484     Elongation factor-1 alpha                       9.01/50.1
  10         58.98      7          gi15100179    Malate dehydrogenase 1                          6.58/36.5
  11         642.98     12         gi19526477    Alpha-crystallin A                              6.20/19.8
  12         164.2      9          gi13162243    Alpha-crystallin B                              6.81/19.6
  13         991.24     9          gi13928956    Beta-crystallin A~4~                            6.37/22.4
  14         274.74     13         gi402766651   Beta-crystallin A~1~                            6.62/25.3
  15         465.73     16         gi9739217     Beta-crystallin B~1~                            7.30/27.6
  16         24.14      18         gi3891676     Beta-crystallin B~2~                            6.80/20.1
  17         1,004.89   13         gi66774108    Beta-crystallin B~3~                            7.58/24.3
  18         644.83     10         gi149045973   Gamma-crystallin A                              8.92/41.5
  19         423.55     10         gi158138485   Gamma-crystallin B                              7.62/21.1
  20         239.81     11         gi126090735   Gamma-crystallin C                              7.63/20.9
  21         578.98     10         gi117472      Gamma-crystallin F                              7.52/21.3
  22         555.58     7          gi14861862    Gamma-crystallin D                              7.37/21.1
  23         286.99     8          gi83753818    Hydrogenated rat gamma E crystallin             7.50/21.1

**Abbreviations:** LC--MS/MS, liquid chromatography tandem mass spectrometry; PI/Mr, isoelectric point/molecular weight.

###### 

The identified homologous of 22 query proteins with blastp against the rat protein database

  Proteins   Accession     Description                                          Symbol
  ---------- ------------- ---------------------------------------------------- --------------------
  1          gi14389299    Vimentin                                             VIM
  2          gi38648857    Tryptophan 5-monooxygenase activation protein        YWHAE
  3          gi27465535    Tubulin beta-5 chain                                 TUBB
  4          gi476007854   Beaded filament structural protein 2                 BFSP2
  5          gi158186655   Beaded filament structural protein 1                 BFSP1
  6          gi94400790    Heat shock protein beta-1                            HSPB1
  7          gi78187979    Glutaredoxin-3                                       GLRX3
  8          gi56090265    Serine-tRNA ligase                                   SARS
  9          gi1220484     Eukaryotic translation elongation factor 1 alpha 1   EEF1A1
  10         gi15100179    Malate dehydrogenase 1                               MDH1
  11         gi19526477    Alpha-crystallin A                                   CRYAA/LOC102724652
  12         gi13162243    Alpha-crystallin B                                   CRYAB
  13         gi13928956    Beta-crystallin A~4~                                 CRYBA4
  14         gi402766651   Beta-crystallin A~1~                                 CRYBA1
  15         gi9739217     Beta-crystallin B~1~                                 CRYBB1
  16         gi3891676     Beta-crystallin B~2~                                 CRYBB2
  17         gi66774108    Beta-crystallin B~3~                                 CRYBB3
  18         gi149045973   Gamma-crystallin A                                   CRYGA
  19         gi158138485   Gamma-crystallin B                                   CRYGB
  20         gi126090735   Gamma-crystallin C                                   CRYGC
  21         gi117472      Gamma-crystallin F                                   Cryge/Crygf
  22         gi14861862    Gamma-crystallin D                                   CRYGD

###### 

The cataract-related protein networks

  ID   Molecules in network                                                                                                                                                                                                                                                                                                                                                                           Score   Focus molecules   Top functions
  ---- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------- ----------------- -----------------------------------------------------------------------------------
  1    26s proteasome, actin, Akt, ARHGAP28, ↑**BFSP1**, ↑**BFSP2**, caspase, ↓**CRYAB**, ↓**CRYAA/LOC102724652**, ↑**CRYBA1**, CRYBA2, ↓**CRYBA4**, ↑**CRYBB1**, ↑**CRYBB2**, ↓**CRYBB3**, ↓**CRYGB**, ↓**CRYGC**, ↑**CRYGD**, D-galactose, ↓**EEF1A1**, ERK1/2, ↑**GLRX3**, Hsf4, HSP, Hsp70, ↑**HSPB1**, insulin, MIP, NF-kB (complex), Pkc(s), ↑**TUBB**, ubiquitin, ↓**VIM**, ↑**YWHAE**, ZFAT   51      18/36             Developmental disorder, ophthalmic disease, organismal injury and abnormalities
  2    ARIH2, CARS, CLIC4, CNN3, ↓**CRYGA**, ↓**Cryge/Crygf**, EIF5, EIF4G2, EIF4G3, HSF4, IPO9, MAF, MAFG, ↓**MDH1**, MDH2, MTBP, NTRK1, NUAK1, PAFAH1B3, PIK3R4, PPA1, PPM1F, PROX1, RGS12, RNF40, ↓**SARS**, TAF1A, THOP1, Top2, TP53, TWIST2, UPP1, USP14, VPS8, VPS33A                                                                                                                           8       4/35              Embryonic development, nervous system development and function, organ development

**Note:** Bold text= protein which was found in our experiment, we can see it was upregulated or downregulated.

[^1]: These authors contributed equally to this work
